|
1
|
Sangha O: Epidemiology of rheumatic
disease. Rheumatology (Oxford). 39 (Suppl 2):S3–S12.
2000.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Joosten LA, Helsen MM, Saxne T, van De Loo
FA, Heinegard D and van Den Berg WB: IL-1 alpha beta blockade
prevents cartilage and bone destruction in murine type II
collagen-induced arthritis, whereas TNF-alpha blockade only
ameliorates joint inflammation. J Immunol. 163:5049–5055.
1999.PubMed/NCBI
|
|
3
|
Haneklaus M, O'Neill LA and Coll RC:
Modulatory mechanisms controlling the NLRP3 inflammasome in
inflammation: Recent developments. Curr Opin Immunol. 25:40–45.
2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Bauernfeind F, Rieger A, Schildberg FA,
Knolle PA, Schmid-Burgk JL and Hornung V: NLRP3 inflammasome
activity is negatively controlled by miR-223. J Immunol.
189:4175–4181. 2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zhong Z, Sanchez-Lopez E and Karin M:
Autophagy, NLRP3 inflammasome and autoinflammatory/immune diseases.
Clin Exp Rheumatol. 34 (4 Suppl 98):S12–S16. 2016.PubMed/NCBI
|
|
6
|
Jo EK, Kim JK, Shin DM and Sasakawa C:
Molecular mechanisms regulating NLRP3 inflammasome activation. Cell
Mol Immunol. 13:148–159. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Martinon F, Mayor A and Tschopp J: The
inflammasomes: Guardians of the body. Annu Rev Immunol. 27:229–265.
2009.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Verma D, Lerm M, Blomgran Julinder R,
Eriksson P, Söderkvist P and Särndahl E: Gene polymorphisms in the
NALP3 inflammasome are associated with interleukin-1 production and
severe inflammation: Relation to common inflammatory diseases?
Arthritis Rheum. 58:888–894. 2008.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Pontillo A, Brandao L, Guimaraes R, Segat
L, Araujo J and Crovella S: Two SNPs in NLRP3 gene are involved in
the predisposition to type-1 diabetes and celiac disease in a
pediatric population from northeast Brazil. Autoimmunity.
43:583–589. 2010.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Bank S, Julsgaard M, Abed OK, Burisch J,
Broder Brodersen J, Pedersen NK, Gouliaev A, Ajan R, Nytoft
Rasmussen D, Honore Grauslund C, et al: Polymorphisms in the NFkB,
TNF-alpha, IL-1beta, and IL-18 pathways are associated with
response to anti-TNF therapy in Danish patients with inflammatory
bowel disease. Aliment Pharmacol Ther. 49:890–903. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhang QB, Qing YF, He YL, Xie WG and Zhou
JG: Association of NLRP3 polymorphisms with susceptibility to
primary gouty arthritis in a Chinese Han population. Clin
Rheumatol. 37:235–244. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kastbom A, Verma D, Eriksson P, Skogh T,
Wingren G and Söderkvist P: Genetic variation in proteins of the
cryopyrin inflammasome influences susceptibility and severity of
rheumatoid arthritis (the Swedish TIRA project). Rheumatology
(Oxford). 47:415–417. 2008.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Mathews RJ, Robinson JI, Battellino M,
Wong C and Taylor JC: Biologics in Rheumatoid Arthritis Genetics
and Genomics Study Syndicate (BRAGGSS). Eyre S, Churchman SM,
Wilson AG, Isaacs JD, et al: Evidence of NLRP3-inflammasome
activation in rheumatoid arthritis (RA); genetic variants within
the NLRP3-inflammasome complex in relation to susceptibility to RA
and response to anti-TNF treatment. Ann Rheum Dis. 73:1202–1210.
2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ben Hamad M, Cornelis F, Marzouk S,
Chabchoub G, Bahloul Z, Rebai A, Fakhfakh F, Ayadi H,
Petit-Teixeira E and Maalej A: Association study of CARD8 (p.C10X)
and NLRP3 (p.Q705K) variants with rheumatoid arthritis in French
and Tunisian populations. Int J Immunogenet. 39:131–136.
2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Addobbati C, da Cruz HLA, Adelino JE, Melo
Tavares Ramos AL, Fragoso TS, Domingues A, Branco Pinto Duarte ÂL,
Oliveira RDR, Louzada-Júnior P, Donadi EA, et al: Polymorphisms and
expression of inflammasome genes are associated with the
development and severity of rheumatoid arthritis in Brazilian
patients. Inflamm Res. 67:255–264. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Choulaki C, Papadaki G, Repa A, Kampouraki
E, Kambas K, Ritis K, Bertsias G, Boumpas DT and Sidiropoulos P:
Enhanced activity of NLRP3 inflammasome in peripheral blood cells
of patients with active rheumatoid arthritis. Arthritis Res Ther.
17(257)2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Arnett FC, Edworthy SM, Bloch DA, McShane
DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS,
et al: The American Rheumatism Association 1987 revised criteria
for the classification of rheumatoid arthritis. Arthritis Rheum.
31:315–324. 1988.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Prevoo ML, van 't Hof MA, Kuper HH, van
Leeuwen MA, van de Putte LB and van Riel PL: Modified disease
activity scores that include twenty-eight-joint counts. Development
and validation in a prospective longitudinal study of patients with
rheumatoid arthritis. Arthritis Rheum. 38:44–48. 1995.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Fransen J, Creemers MC and Van Riel PL:
Remission in rheumatoid arthritis: Agreement of the disease
activity score (DAS28) with the ARA preliminary remission criteria.
Rheumatology (Oxford). 43:1252–1255. 2004.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Castaño-Rodríguez N, Kaakoush NO, Goh KL,
Fock KM and Mitchell HM: The NOD-like receptor signaling pathway in
Helicobacter pylori infection and related gastric cancer: A
case-control study and gene expression analyses. PLoS One.
9(e98899)2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
22
|
McInnes IB and Schett G: The pathogenesis
of rheumatoid arthritis. N Engl J Med. 365:2205–2219.
2011.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Muruve DA, Pétrilli V, Zaiss AK, White LR,
Clark SA, Ross PJ, Parks RJ and Tschopp J: The inflammasome
recognizes cytosolic microbial and host DNA and triggers an innate
immune response. Nature. 452:103–107. 2008.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kim HW, Kwon YJ, Park BW, Song JJ, Park YB
and Park MC: Differential expressions of NOD-like receptors and
their associations with inflammatory responses in rheumatoid
arthritis. Clin Exp Rheumatol. 35:630–637. 2017.PubMed/NCBI
|
|
25
|
Ruscitti P, Cipriani P, Di Benedetto P,
Liakouli V, Berardicurti O, Carubbi F, Ciccia F, Alvaro S, Triolo G
and Giacomelli R: Monocytes from patients with rheumatoid arthritis
and type 2 diabetes mellitus display an increased production of
interleukin (IL)-1β via the nucleotide binding domain and
leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome
activation: A possible implication for therapeutic decision in
these patients. Clin Exp Immunol. 182:35–44. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Kim HY, Kim SJ and Lee SM: Activation of
NLRP3 and AIM2 inflammasomes in Kupffer cells in hepatic
ischemia/reperfusion. FEBS J. 282:259–270. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Martinon F, Pétrilli V, Mayor A, Tardivel
A and Tschopp J: Gout-associated uric acid crystals activate the
NALP3 inflammasome. Nature. 440:237–241. 2006.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Iyer SS, Pulskens WP, Sadler JJ, Butter
LM, Teske GJ, Ulland TK, Eisenbarth SC, Florquin S, Flavell RA,
Leemans JC and Sutterwala FS: Necrotic cells trigger sterile
inflammatory response through the Nlrp3 inflammasome. Proc Natl
Acad Sci USA. 106:20388–20393. 2009.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Fu Q, Gao Y, Zhao H, Wang Z and Wang J:
Galangin protects human rheumatoid arthritis fibroblast-like
synoviocytes via suppression of the NF-κB/NLRP3 pathway. Mol Med
Rep. 18:3619–3624. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Liu Y, Wei W, Wang Y, Wan C, Bai Y, Sun X,
Ma J and Zheng F: TNF-α/calreticulin dual signaling induced NLRP3
inflammasome activation associated with HuR nucleocytoplasmic
shuttling in rheumatoid arthritis. Inflamm Res. 68:597–611.
2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Shen HH, Yang YX, Meng X, Luo XY, Li XM,
Shuai ZW, Ye DQ and Pan HF: NLRP3: A promising therapeutic target
for autoimmune diseases. Autoimmun Rev. 17:694–702. 2018.PubMed/NCBI View Article : Google Scholar
|
